Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Neuroradiology
Published in: Clinical Neuroradiology 4/2014

01-12-2014 | Original Article

Differentiation of Primary Central Nervous System Lymphomas from High-Grade Gliomas by rCBV and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging

Authors: Z. Xing, MD, R. X. You, MD, J. Li, MD, Y. Liu, MD, D. R. Cao, MD

Published in: Clinical Neuroradiology | Issue 4/2014

Login to get access

Abstract

Purpose

Primary central nervous system lymphoma (PCNSL) and high-grade glioma (HGG) may have similar enhancement patterns on magnetic resonance imaging (MRI), making the differential diagnosis difficult or even impractical. Relative cerebral blood volume (rCBV) and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced (DSC) perfusion MR imaging may help distinguish PCNSL from HGG. The purpose of this study was to evaluate the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of these two imaging parameters used alone or in combination for differentiating PCNSL from HGG.

Methods

A total of 12 patients with PCNSL and 26 patients with HGG were examined using a 3T scanner. rCBV and percentage of signal intensity recovery were obtained and receiver operating characteristic (ROC) analysis was performed to determine optimum thresholds for tumor differentiation. Sensitivity, specificity, PPV, NPV, and accuracy for identifying the tumor types were also calculated.

Results

The optimum threshold of 2.56 for rCBV provided sensitivity, specificity, PPV, NPV, and accuracy of 96.2, 90, 92.6, 94.7, and 93.5 %, respectively, for determining PCNSL. A threshold value of 0.89 for percentage of signal intensity recovery optimized differentiation of PCNSL and HGG with a sensitivity, specificity, PPV, NPV, and accuracy of 100, 88.5, 87, 100, and 93.5 %, respectively. Combining rCBV with the percentage of signal intensity recovery further improved the differentiation of PCNSL and HGG with a specificity of 98.5 % and an accuracy of 95.7 %.

Conclusions

The combination of rCBV measurement with percentage of signal intensity recovery can help in more accurate differentiation of PCNSL from HGG.
Literature
1.
Koeller KK, Smirniotopoulos JG, Jones RV. Primary central nervous system lymphoma: radiologic-pathologic correlation. Radiographics. 1997;17:1497–526.PubMedCrossRef
2.
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109.PubMedCentralPubMedCrossRef
3.
Buhring U, Herrlinger U, Krings T, Thiex R, Weller M, Kuker W. MRI features of primary central nervous system lymphomas at presentation. Neurology. 2001;57:393–6.PubMedCrossRef
4.
Liu HY, Zhang XL, Chen YP, Qiu SJ. Characteristic imaging features of primary central nervous system lymphoma in comparison with pathological findings. Nan Fang Yi Ke Da Xue Xue Bao. 2009;29:333–6.PubMed
5.
Tang YZ, Booth TC, Bhogal P, Malhotra A, Wilhelm T. Imaging of primary central nervous system lymphoma. Clin Radiol. 2011;66:768–77.PubMedCrossRef
6.
Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology. 2002;223:11–29.PubMedCrossRef
7.
Covarrubias DJ, Rosen BR, Lev MH. Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist. 2004;9:528–37.PubMedCrossRef
8.
Barbier EL, Lamalle L, Decorps M. Methodology of brain perfusion imaging. J Magn Reson Imaging. 2001;13:496–520.PubMedCrossRef
9.
Cha S. Perfusion MR imaging: basic principles and clinical applications. Magn Reson Imaging Clin N Am. 2003;11:403–13.PubMedCrossRef
10.
Preul C, Kuhn B, Lang EW, Mehdorn HM, Heller M, Link J. Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging. Eur J Radiol. 2003;48:244–51.PubMedCrossRef
11.
Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol. 2004;25:746–55.PubMed
12.
Bulakbasi N, Kocaoglu M, Farzaliyev A, Tayfun C, Ucoz T, Somuncu I. Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol. 2005;26:2187–99.PubMed
13.
Hakyemez B, Erdogan C, Bolca N, Yildirim N, Gokalp G, Parlak M. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging. 2006;24:817–24.PubMedCrossRef
14.
Burger PC. Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to treatment. Semin Oncol. 1986;13:16–26.PubMed
15.
Folkerth RD. Descriptive analysis and quantification of angiogenesis in human brain tumors. J Neurooncol. 2000;50:165–72.PubMedCrossRef
16.
Folkerth RD. Histologic measures of angiogenesis in human primary brain tumors. Cancer Treat Res. 2004;117:79–95.PubMedCrossRef
17.
Sharma S, Sharma MC, Gupta DK, Sarkar C. Angiogenic patterns and their quantitation in high grade astrocytic tumors. J Neurooncol. 2006;79:19–30.PubMedCrossRef
18.
Kim EY, Kim SS. Magnetic resonance findings of primary central nervous system T-cell lymphoma in immunocompetent patients. Acta Radiol. 2005;46:187–92.PubMedCrossRef
19.
Weber MA, Zoubaa S, Schlieter M, Juttler E, Huttner HB, Geletneky K, et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology. 2006;66:1899–906.PubMedCrossRef
20.
Lee IH, Kim ST, Kim HJ, Kim KH, Jeon P, Byun HS. Analysis of perfusion weighted image of CNS lymphoma. Eur J Radiol. 2010;76:48–51.PubMedCrossRef
21.
Cho SK, Na DG, Ryoo JW, Roh HG, Moon CH, Byun HS, et al. Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors. Korean J Radiol. 2002;3:171–9.PubMedCentralPubMedCrossRef
22.
Hartmann M, Heiland S, Harting I, Tronnier VM, Sommer C, Ludwig R, et al. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett. 2003;338:119–22.PubMedCrossRef
23.
Liao W, Liu Y, Wang X, Jiang X, Tang B, Fang J, et al. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol. 2009;50:217–25.PubMedCrossRef
24.
Lev MH. Gliomatosis cerebri has normal relative blood volume: really?! Who cares? Should you? AJNR Am J Neuroradiol. 2002;23:345–6.PubMed
25.
Lupo JM, Cha S, Chang SM, Nelson SJ. Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. AJNR Am J Neuroradiol. 2005;26:1446–54.PubMed
26.
Cha S, Lupo JM, Chen MH, Lamborn KR, McDermott MW, Berger MS, et al. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol. 2007;28:1078–84.PubMedCrossRef
27.
Wetzel SG, Cha S, Johnson G, Lee P, Law M, Kasow DL, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology. 2002;224:797–803.PubMedCrossRef
28.
Heiland S, Benner T, Debus J, Rempp K, Reith W, Sartor K. Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain-barrier. Magn Reson Imaging. 1999;17:21–7.PubMedCrossRef
29.
Wang S, Kim S, Chawla S, Wolf RL, Knipp DE, Vossough A, et al. Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol. 2011;32:507–14.PubMedCrossRef
30.
Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology. 1994;191:41–51.PubMedCrossRef
31.
Sugahara T, Korogi Y, Kochi M, Ikushima I, Hirai T, Okuda T, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol. 1998;171:1479–86.PubMedCrossRef
32.
Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, Zagzag D, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology. 1999;211:791–8.PubMedCrossRef
33.
Sugahara T, Korogi Y, Kochi M, Ikushima I, Shigematu Y, Hirai T, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging. 1999;9:53–60.PubMedCrossRef
34.
Guo AC, Cummings TJ, Dash RC, Provenzale JM. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology. 2002;224:177–83.PubMedCrossRef
35.
Barajas RF Jr., Rubenstein JL, Chang JS, Hwang J, Cha S. Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR Am J Neuroradiol. 2010;31:60–6.PubMedCentralPubMedCrossRef
36.
Yamasaki F, Kurisu K, Satoh K, Arita K, Sugiyama K, Ohtaki M, et al. Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology. 2005;235:985–91.PubMedCrossRef
37.
Kitis O, Altay H, Calli C, Yunten N, Akalin T, Yurtseven T. Minimum apparent diffusion coefficients in the evaluation of brain tumors. Eur J Radiol. 2005;55:393–400.PubMedCrossRef
38.
Toh CH, Castillo M, Wong AM, Wei KC, Wong HF, Ng SH, et al. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol. 2008;29:471–5.PubMedCrossRef
39.
Server A, Kulle B, Maehlen J, Josefsen R, Schellhorn T, Kumar T, et al. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema. Acta Radiol. 2009;50:682–9.PubMedCrossRef
40.
Doskaliyev A, Yamasaki F, Ohtaki M, Kajiwara Y, Takeshima Y, Watanabe Y, et al. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T. Eur J Radiol. 2012;81:339–44.PubMedCrossRef
41.
Harting I, Hartmann M, Jost G, Sommer C, Ahmadi R, Heiland S, et al. Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy. Neurosci Lett. 2003;342:163–6.PubMedCrossRef
42.
Chawla S, Zhang Y, Wang S, Chaudhary S, Chou C, O’Rourke DM, et al. Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases. J Comput Assist Tomogr. 2010;34:836–41.PubMedCrossRef
43.
Lee EJ, terBrugge K, Mikulis D, Choi DS, Bae JM, Lee SK, et al. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions. AJR Am J Roentgenol. 2011;196:71–6.PubMedCrossRef
Metadata
Title
Differentiation of Primary Central Nervous System Lymphomas from High-Grade Gliomas by rCBV and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging
Authors
Z. Xing, MD
R. X. You, MD
J. Li, MD
Y. Liu, MD
D. R. Cao, MD
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Clinical Neuroradiology / Issue 4/2014
Print ISSN: 1869-1439
Electronic ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-013-0255-5

Other articles of this Issue 4/2014

Clinical Neuroradiology 4/2014 Go to the issue

Review Article

Skull Base Chondroid Chordoma: Atypical Case Manifesting as Intratumoral Hemorrhage and Literature Review

Editorial

Studies in Intracranial Stenting: We Must Not Retire from the Game of Science

Original Article

Definition of Ktrans and FA Thresholds for Better Assessment of Experimental Glioma Using High-field MRI: A Feasibility Study

Original Article

Temporal Evolution of Intraparenchymal Hyperdensity After Intra-arterial Therapy in Patients with Ischemic Stroke: Optimal Discrimination Between Hemorrhage and Iodinated Contrast

Clinical Case

Freiburg Neuropathology Case Conference: Periorbital Bone Lesion Causing Proptosis in a 31-Year-Old Patient

Correspondence

Minute Subsequent Fracture at Prophylactically Treated Adjacent Vertebra After Percutaneous Vertebroplasty